glp-1 crohn's Medications: Reimagining the Treatment Paradigm for Severe Disease A surprising role for enteroendocrine

(Lausanne) 2013;4:102

A limited number of studies have reported increased systemic levels of claudins as a marker for impaired intestinal barrier function, e.g., increased serum claudin-5 in children with attention deficit hyperactivity disorder (67) and increased urinary claudin-3 in patients with active Crohn's disease which was associated with decreased claudin-3 staining in intestinal biopsies (68)

Preliminary findings indicated that EA led to a clinically meaningful decrease in hepatic fat accumulation compared to sham acupuncture, supporting the therapeutic value of EA in reducing steatosis (83)

A version of this story originally appeared in the Good News newsletter

The liver and cardiovascular system engage in complex crosstalk through various mechanisms to maintain homeostasis and contribute to disease progression when dysregulated

While GLP-1 is naturally occurring in your body, Ozempic is a synthetic medication administered through injection to provide sustained therapeutic effects